On this page
Wolverine peptide dosage: what do people actually take?
One clearly documented daily schedule is 1 mg of a 1:1 Wolverine blend: 500 mcg BPC-157 + 500 mcg TB-500. The accounts below include once-daily use, a divided morning/evening schedule, and a different protocol using separate BPC-157 and TB-500 vials.726
People use these experimental schedules hoping for less joint or tendon discomfort, easier movement and a return to training. The numbers below describe what the authors took; they are not an established medical regimen.
Wolverine peptide stack dosing chart: daily amounts and cycles
| Reported schedule | Daily or weekly amount | Combined amount per week | Reported cycle |
|---|---|---|---|
| Once-daily 1:1 blend17 | 500 mcg BPC-157 + 500 mcg TB-500 once daily | 7 mg | 4 weeks in one account; about 2 months in another |
| Split daily blend6 | 500 mcg of the combined blend twice daily | 7 mg | 4 weeks reported at the first update |
| Separate ingredient schedule2 | BPC-157: 500 mcg twice daily. TB-500: 2 mg twice weekly. | 11 mg: 7 mg BPC-157 + 4 mg TB-500 | About 3 months |
The split-dose author stated the combined blend amount without separately confirming its ingredient ratio. The two-month user also described a brief pause after eye irritation; that context is covered below. These are ingredient experiences from public posts, not reviews of this website's products.
Wolverine peptide dosage per day and per week
Every-day blend use
At 1 mg of a 1:1 blend every day, the weekly total is 7 mg combined: 3.5 mg BPC-157 and 3.5 mg TB-500. That describes seven days of use, including rest days. The two-month blend account described once-daily use.7
A divided daily schedule
Another contributor reported 500 mcg of blend twice daily. This also adds up to 1 mg a day and 7 mg a week; dividing a daily amount does not double it.6
Daily BPC-157 with twice-weekly TB-500
The separate-vial example uses 1 mg BPC-157 per day and 4 mg TB-500 per week. Its combined weekly total is 11 mg. A 1:1 premixed vial or pen cannot reproduce that unequal ingredient schedule: every quantity taken from the blend supplies equal masses of both peptides.2
How long do people run a Wolverine peptide cycle?
Four- and eight-week courses appear in the original reports, alongside longer use of about three months. Those are examples of community practice. No human study establishes a safe maximum cycle length or shows that a longer Wolverine cycle produces better recovery.1234
| Duration | What was reported | Practical upside | Tradeoff |
|---|---|---|---|
| 4 weeks | A completed daily-blend course; improvement was still developing afterward.1 | Less product, expense and time exposed than a longer course at the same daily amount. | A late response leaves little time within the course to see whether it lasts. |
| 8 weeks | An 8-week shoulder account reported initial improvement after about 2½ weeks and further improvement during the course, alongside rehabilitation.3 | More time to observe comfort and function during a rehabilitation period. | Eight weeks uses twice as much product as four at the same daily amount. The report did not describe a fully recovered shoulder. |
| About 3 months | Less pain; clicking and swelling gone. Reported MRI still showed tears.2 | A longer observation period for a persistent problem. | More expense and longer exposure, without evidence that extending use guarantees additional healing. |
How much blend does a cycle use?
For an unchanged 1 mg total daily schedule, the quantities are:
| Length | Total blend | Each ingredient | 20 mg vials | 40 mg pens |
|---|---|---|---|---|
| 4 weeks / 28 days | 28 mg | 14 mg | 2 | 1 |
| 6 weeks / 42 days | 42 mg | 21 mg | 3 | 2 |
| 8 weeks / 56 days | 56 mg | 28 mg | 3 | 2 |
| 12 weeks / 84 days | 84 mg | 42 mg | 5 | 3 |
These package counts are calculations, not new protocols. They assume the stated contents are available without wastage and do not establish how long an opened vial or pen remains usable. See market prices and package costs for the current price comparison.
What effects do people report during a Wolverine peptide cycle?
The changes people describe are concrete improvements in comfort and activity:
- Shoulder comfort: less pain with pressing movements.1
- Movement during rehabilitation: easier shoulder movement while continuing exercises.3
These accounts do not establish muscle growth, fat loss or structural repair of an injury. The Wolverine peptide before-and-after reviews show the original experiences and when each person noticed a change.
Does 500 mcg mean 500 mcg of each peptide?
Not when the figure describes the total blend. In the featured 1:1 products, half of the total mass is BPC-157 and half is TB-500.
| Total Wolverine blend | BPC-157 | TB-500 |
|---|---|---|
| 500 mcg | 250 mcg | 250 mcg |
| 1,000 mcg / 1 mg | 500 mcg | 500 mcg |
| 2,000 mcg / 2 mg | 1 mg | 1 mg |
“500 mcg each” means 1 mg combined. “500 mcg of Wolverine” means 500 mcg combined unless the author explicitly says otherwise.
Wolverine vial and pen: amounts and concentration
The 20 mg vial contains 10 mg BPC-157 + 10 mg TB-500. The 40 mg pen contains 20 mg + 20 mg in 3 mL. The pen is already a liquid; its combined concentration is approximately 13.33 mg/mL, or 6.67 mg/mL of each ingredient.
The vial starts as powder, so its concentration depends on the volume used for reconstitution. The original vial certificate is available here.5 The next section covers vial preparation and concentration examples.
How to reconstitute a 20 mg Wolverine peptide vial
For the 20 mg vial, the worked example below uses 2 mL of bacteriostatic water. This gives approximately 10 mg of combined peptide per mL: 5 mg BPC-157 and 5 mg TB-500 per mL. Research suppliers describe 1–2 mL preparations, but the compatible diluent and storage instructions must come from the actual product documentation. This example is not a validated formulation for human injection.810
What you need
The 20 mg freeze-dried vial, the specified sterile diluent, a new sterile transfer syringe large enough to measure 2 mL, a new sterile needle, alcohol wipes, a label and a sharps container. Use a clean preparation area away from a sink.9
- Prepare the vials. Wash your hands and clean the work surface. Check the vial and diluent seals and expiry dates. If the peptide vial is cold, let it reach room temperature while still sealed.911
- Clean both rubber stoppers. Remove the protective flip caps, keeping the rubber stoppers in place. Wipe each stopper with 70% alcohol and let it air-dry. Avoid touching the cleaned surfaces.13
- Measure the diluent. With new sterile transfer equipment, withdraw 2 mL of the compatible diluent for this example. Read the syringe's mL scale; the target here is a liquid volume, not 2 mg of peptide.
- Add it slowly. Direct the liquid against the inside wall of the peptide vial so it runs down gently. Avoid a forceful stream onto the powder.12
- Swirl gently until dissolved. Allow the powder to dissolve; do not shake the vial vigorously. Stop if unexpected cloudiness, discoloration or particles remain.1210
- Label the finished vial. Record the date, diluent and volume. For this example write “20 mg / 2 mL; 10 mg/mL combined; 5 mg/mL of each peptide.” Follow the product's storage and discard instructions. Dispose of used needles in a sharps container.
How much peptide is in the measured liquid?
For the 2 mL example only, these are the concentration conversions. A U-100 syringe has 100 units per mL; its markings describe volume. They are not the click settings on a pen.
| Liquid volume | U-100 scale | Total blend | BPC-157 + TB-500 |
|---|---|---|---|
| 0.05 mL | 5 units | 500 mcg | 250 mcg + 250 mcg |
| 0.10 mL | 10 units | 1 mg | 500 mcg + 500 mcg |
| 0.20 mL | 20 units | 2 mg | 1 mg + 1 mg |
These rows convert concentration into volume; they do not select a dose. With 3 mL instead of 2 mL, the concentration is lower: approximately 6.67 mg/mL combined, or 3.33 mg/mL of each ingredient. The 2 mL chart would no longer apply.
Storage after reconstitution
Keep the mixed preparation under its documented storage conditions and record its discard date. The supplied vial COA does not establish a post-mixing shelf life, so a universal “28 days in the fridge” cannot be assigned to this vial. Pfizer's diluent instructions require manufacturer directions before storing a reconstituted preparation. Discard a vial if contamination is suspected, even if it still looks clear.109
Preloaded pen: the 40 mg / 3 mL pen is already mixed. Do not add water or transfer this vial chart to its click dial.
Wolverine peptide dosage FAQ
How long does one 20 mg Wolverine vial last?
At 1 mg of total blend per day, its stated contents equal 20 daily amounts. The 40 mg pen equals 40 at the same daily amount. This is a quantity calculation; the product’s documented storage and discard period still applies.
Do people take Wolverine once or twice a day?
Should the Wolverine stack be taken in the morning or at night?
How long do people take off between cycles?
Can a 1:1 blend follow a separate BPC-157 and TB-500 protocol?
Only if the desired amounts and timing match the fixed blend. A blend always supplies equal masses together. It cannot give BPC-157 every day while independently giving TB-500 only twice weekly.
Do I need to reconstitute the 40 mg pen?
No. The featured pen is preloaded with 40 mg total in 3 mL. Reconstitution applies to the 20 mg freeze-dried vial. A pen’s click size is device-specific, so its 3 mL fill alone does not tell you the amount delivered per click.
Is a 12-week cycle better than four or eight weeks?
No direct human comparison establishes that. A 12-week course at an unchanged daily amount uses three times as much product as four weeks and extends exposure accordingly. Longer use is not evidence that an injury has fully healed.
What changes if I add 3 mL instead of 2 mL?
The same 20 mg is spread through more liquid. At 3 mL, the combined concentration is about 6.67 mg/mL, with 3.33 mg/mL of each peptide. At 2 mL it is 10 mg/mL combined. Use the concentration for the volume actually added.
Does 10 units mean the same amount for every vial?
No. On a U-100 syringe, 10 units is 0.1 mL. With a 20 mg vial mixed in 2 mL, that volume contains 1 mg combined. With the same vial mixed in 3 mL, it contains about 0.667 mg combined. A pen's clicks are a separate device setting.
What if the mixed vial is cloudy or has particles?
Side effects and longer Wolverine cycles
The two-month daily-blend author reported a day of eye irritation during week two, briefly stopped, and then resumed; the cause was uncertain.7 A community report is not a reason to push through a new symptom or keep increasing a dose.
The FDA review describes insufficient clinical safety data for BPC-157 and concerns about immune responses and peptide-related impurities.4 No established long-term safety evidence supports year-round Wolverine maintenance. Persistent injury symptoms or new adverse effects call for medical assessment, rather than automatically extending a cycle.
Sources and Original Documentation
- 1Shoulder account — u/604HustleOriginal community report.
- 2Meniscus account — u/dothethizzledanceOriginal community report.
- 3Positive experience with BPC-157 and TB-500 for shoulder issuesu/Ok-Yard-5338; eight-week course with continued shoulder exercises.
- 4FDA — BPC-157-related bulk drug substances reviewReview of clinical evidence, characterization and safety concerns.
- 5Original Wolverine Blend 20 mg vial certificateSupplied in-house report, lot PL-2609-011.
- 6Community schedules — firsthand discussionu/jmwest51 and u/SchoolAccording2418.
- 7Taking the Wolverine stack — original account and follow-upu/jachybochsss; 500 mcg of each daily for about two months, including a temporary pause after eye irritation.
- 8Peptide Sciences — laboratory mixing FAQThe supplier describes 1–2 mL bacteriostatic-water preparations for its research vials. This is background for the worked dilution example, not validation of the featured vial.
- 9CDC — safe vial handling and aseptic preparationClean preparation areas, hand hygiene, disinfected stoppers, new sterile equipment and discarding compromised vials.
- 10Pfizer — Bacteriostatic Water for Injection, USPDiluent compatibility, visual inspection, aseptic technique and product-specific directions for storage after mixing.
- 11Bachem — handling and storage guidelines for peptidesAllowing cold sealed containers to reach ambient temperature before opening; solution stability and storage depend on the material.
- 12Wolverine Blend 10 mg + 10 mg — product handling summaryPrymaLab, SDS PL-SDS-187, handling summary accessed November 2, 2026: slow diluent addition along the vial wall; do not shake.
- 13CDC — injection and sharps safetyWipe vial stoppers with 70% alcohol and allow them to air-dry before entry.